Protective effects of Asiatic acid against pelvic inflammatory disease in rats

Kong,Dejia; Fu,Ping; Zhang,Qin; Ma,Xian; Jiang,Ping

doi:10.3892/etm.2019.7498

Protective effects of Asiatic acid against pelvic inflammatory disease in rats

Authors:
- Dejia Kong
- Ping Fu
- Qin Zhang
- Xian Ma
- Ping Jiang
View Affiliations

Affiliations: Department of Chinese Gynecology, Hangzhou Women's Hospital, Hangzhou, Zhejiang 310008, P.R. China, Department of Chinese Gynecology, The Affiliated Guang‑Xing Hospital of Zhejiang Traditional Chinese Medicine University, Hangzhou, Zhejiang 310007, P.R. China
Published online on: April 17, 2019 https://doi.org/10.3892/etm.2019.7498
Pages: 4687-4692

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Asiatic acid (AA) is one of the major components of the Chinese herb Centella asiatica and exerts a variety of pharmacological activities. However, the pharmacological effects of AA on pelvic inflammatory disease (PID) remain unknown. The purpose of the present study was to investigate the therapeutic efficacy and potential mechanisms of AA on PID in rats. A total of 75 female Sprague Dawley rats were randomly divided into the following five groups: A control group; a PID group; a PID + AA 5 mg/kg group; a PID + AA 35 mg/kg group; and a PID + AA 75 mg/kg group. Changes in cytokine and chemokine levels, myeloperoxidase (MPO) activity, nucleotide‑binding domain‑like receptor protein 3 (NLRP3) inflammasome and nuclear factor‑κB (NF‑κB) activation, oxidative stress and cleaved caspase‑3 were measured. AA treatment significantly decreased the excessive production of cytokines and chemokines and suppressed MPO activity and the activation of NLRP3 inflammasome, NF‑κB and caspase‑3, as well as oxidative stress. These results suggest that AA exhibits potent anti‑inflammatory and antioxidant effects in rats with pathogen‑induced PID and that the mechanism of these anti‑inflammatory effects may be associated with the suppression of NLRP3 inflammasome activation and the NF‑κB pathway.

View Figures

View References

1	Gradison M: Pelvic inflammatory disease. Am Fam Physician. 85:791–796. 2012.PubMed/NCBI
2	Newton D, Bayly C, Fairley CK, Chen M, Keogh L, Temple-Smith M, Williams H, McNamee K, Fisher J, Henning D, et al: Women's experiences of pelvic inflammatory disease: Implications for health-care professionals. J Health Psychol. 19:618–628. 2014. View Article : Google Scholar : PubMed/NCBI
3	Ross JD: Pelvic inflammatory disease. BMJ Clin Evid. 2013:16062013.PubMed/NCBI
4	Bu X, Liu Y, Lu Q and Jin Z: Effects of ‘Danzhi Decoction’ on chronic pelvic pain, hemodynamics, and proinflammatory factors in the murine model of sequelae of pelvic inflammatory disease. Evid Based Complement Alternat Med. 2015:5472512015. View Article : Google Scholar : PubMed/NCBI
5	Dhasmana D, Hathorn E, McGrath R, Tariq A and Ross JD: The effectiveness of nonsteroidal anti-inflammatory agents in the treatment of pelvic inflammatory disease: A systematic review. Syst Rev. 3:792014. View Article : Google Scholar : PubMed/NCBI
6	Tee YT, Wang PH, Yang SF, Tsai HT, Lee SK, Ko JL, Lin LY and Chen SC: Correlation of plasma osteopontin and neutrophil gelatinase-associated lipocalin levels with the severity and clinical outcome of pelvic inflammatory disease. Taiwan J Obstet Gynecol. 53:158–161. 2014. View Article : Google Scholar : PubMed/NCBI
7	Kayagaki N, Stowe IB, Lee BL, O'Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, et al: Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 526:666–671. 2015. View Article : Google Scholar : PubMed/NCBI
8	Lamkanfi M and Dixit VM: Mechanisms and functions of inflammasomes. Cell. 157:1013–1022. 2014. View Article : Google Scholar : PubMed/NCBI
9	Lin TH, Yao Z, Sato T, Keeney M, Li C, Pajarinen J, Yang F, Egashira K and Goodman SB: Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: A preliminary report. Acta Biomater. 10:3747–3755. 2014. View Article : Google Scholar : PubMed/NCBI
10	Han L, Sun J, Lu CJ, Zhao RZ, Lu Y, Lin HJ and Wei JA: Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression. Int Immunopharmacol. 44:226–233. 2017. View Article : Google Scholar : PubMed/NCBI
11	Karkeni E, Bonnet L, Astier J, Couturier C, Dalifard J, Tourniaire F and Landrier JF: All-trans-retinoic acid represses chemokine expression in adipocytes and adipose tissue by inhibiting NF-κB signaling. J Nutr Biochem. 42:101–107. 2017. View Article : Google Scholar : PubMed/NCBI
12	Burke SJ, Stadler K, Lu D, Gleason E, Han A, Donohoe DR, Rogers RC, Hermann GE, Karlstad MD and Collier JJ: IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB. Am J Physiol Endocrinol Metab. 309:E715–E726. 2015. View Article : Google Scholar : PubMed/NCBI
13	Zou W, Xiao Z, Wen X, Luo J, Chen S, Cheng Z, Xiang D, Hu J and He J: The anti-inflammatory effect of Andrographis paniculata (Burm. f.) Nees on pelvic inflammatory disease in rats through down-regulation of the NF-κB pathway. BMC Complement Altern Med. 16:4832016. View Article : Google Scholar : PubMed/NCBI
14	Zou W, Wen X, Sheng X, Zheng YI, Xiao Z, Luo J, Chen S, Wang Y, Cheng Z, Xiang D and Nie Y: Gas chromatography-mass spectrometric method-based urine metabolomic profile of rats with pelvic inflammatory disease. Exp Ther Med. 11:1653–1660. 2016. View Article : Google Scholar : PubMed/NCBI
15	Workowski KA and Bolan GA; Centers for Disease Control Prevention, : Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64. 64:1–137. 2015.
16	Jiang W, Li M, He F, Bian Z, He Q, Wang X, Yao W and Zhu L: Neuroprotective effect of asiatic acid against spinal cord injury in rats. Life Sci. 157:45–51. 2016. View Article : Google Scholar : PubMed/NCBI
17	Jiang W, Li M, He F, Yao W, Bian Z, Wang X and Zhu L: Protective effects of asiatic acid against spinal cord injury-induced acute lung injury in rats. Inflammation. 39:1853–1861. 2016. View Article : Google Scholar : PubMed/NCBI
18	Pakdeechote P, Bunbupha S, Kukongviriyapan U, Prachaney P, Khrisanapant W and Kukongviriyapan V: Asiatic acid alleviates hemodynamic and metabolic alterations via restoring eNOS/iNOS expression, oxidative diet-induced metabolic syndrome rats. Nutrients. 6:355–370. 2014. View Article : Google Scholar : PubMed/NCBI
19	Lee JW, Park HA, Kwon OK, Jang YG, Kim JY, Choi BK, Lee HJ, Lee S, Paik JH, Oh SR, et al: Asiatic acid inhibits pulmonary inflammation induced by cigarette smoke. Int Immunopharmacol. 39:208–217. 2016. View Article : Google Scholar : PubMed/NCBI
20	Morton DB and Griffiths PH: Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec. 116:431–436. 1985. View Article : Google Scholar : PubMed/NCBI
21	Liu J, Yi L, Xiang Z, Zhong J, Zhang H and Sun T: Resveratrol attenuates spinal cord injury-induced inflammatory damage in rat lungs. Int J Clin Exp Pathol. 8:1237–1246. 2015.PubMed/NCBI
22	Guo W, Liu W, Jin B, Geng J, Li J, Ding H, Wu X, Xu Q, Sun Y and Gao J: Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation. Int Immunopharmacol. 24:232–238. 2015. View Article : Google Scholar : PubMed/NCBI
23	Li Z, Xiao X and Yang M: Asiatic acid inhibits lipopolysaccharide-induced acute lung injury in mice. Inflammation. 39:1642–1648. 2016. View Article : Google Scholar : PubMed/NCBI
24	Hao C, Wu B, Hou Z, Xie Q, Liao T, Wang T and Ma D: Asiatic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts. Int Immunopharmacol. 50:313–318. 2017. View Article : Google Scholar : PubMed/NCBI
25	Gilroy DW: Eicosanoids and the endogenous control of acute inflammatory resolution. Int J Biochem Cell Biol. 42:524–528. 2010. View Article : Google Scholar : PubMed/NCBI
26	Jiang W, Huang Y, He F, Liu J, Li M, Sun T, Ren W, Hou J and Zhu L: Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation, controls inflammation, and alleviates histopathology in a rat model of spinal cord injury. Spine (Phila Pa 1976). 41:E330–E334. 2016. View Article : Google Scholar : PubMed/NCBI
27	Kamimura D, Ishihara K and Hirano T: IL-6 signal transduction and its physiological roles: The signal orchestration model. Rev Physiol Biochem Pharmacol. 149:1–38. 2003. View Article : Google Scholar : PubMed/NCBI
28	Lee SA, Tsai HT, Ou HC, Han CP, Tee YT, Chen YC, Wu MT, Chou MC, Wang PH and Yang SF: Plasma interleukin-1beta, −6, −8 and tumor necrosis factor-alpha as highly informative markers of pelvic inflammatory disease. Clin Chem Lab Med. 46:997–1003. 2008. View Article : Google Scholar : PubMed/NCBI
29	Dash SK, Chattopadhyay S, Dash SS, Tripathy S, Das B, Mahapatra SK, Bag BG, Karmakar P and Roy S: Self assembled nano fibers of betulinic acid: A selective inducer for ROS/TNF-alpha pathway mediated leukemic cell death. Bioorg Chem. 63:85–100. 2015. View Article : Google Scholar : PubMed/NCBI
30	Baldwin AG, Brough D and Freeman S: Inhibiting the inflammasome: A chemical perspective. J Med Chem. 59:1691–1710. 2016. View Article : Google Scholar : PubMed/NCBI
31	Ding W, Guo H, Xu C, Wang B, Zhang M and Ding F: Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury. Oncotarget. 7:17479–17491. 2016. View Article : Google Scholar : PubMed/NCBI
32	Jing W, Chunhua M and Shumin W: Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro. Toxicol Appl Pharmacol. 285:128–135. 2015. View Article : Google Scholar : PubMed/NCBI